Interpreting the impact of hydroxychloroquine prophylaxis on SARS-CoV-2 infection
Indian J Med Res
.
2021 May;153(5&6):564-565.
doi: 10.4103/ijmr.ijmr_1092_21.
Authors
Reetika Malik Yadav
1
,
Manisha Rajan Madkaikar
2
Affiliations
1
Department of Pediatric Immunology, ICMR-National Institute of Immunohematology, Mumbai 400 012, Maharashtra, India.
2
ICMR-National Institute of Immunohematology, Mumbai 400 012, Maharashtra, India.
PMID:
34414921
PMCID:
PMC8555592
DOI:
10.4103/ijmr.ijmr_1092_21
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19 Drug Treatment*
Coronavirus Infections*
Humans
Hydroxychloroquine / therapeutic use
SARS-CoV-2
Substances
Hydroxychloroquine